After the initial weeks, the dose may be increased to 0.5 mg, 1 mg, or even higher, depending on the treatment goals and the patients tolerance
Harik L, Perezgrovas-Olaria R, Soletti G Jr, et al
Pfizer, after discontinuing its initial danuglipron candidate due to safety concerns in April 2025, re-entered the race through a $10 billion acquisition of clinical-stage biotech Metsera in November 2025, securing a next-generation obesity pipeline [43]
The changes in diet and gut microbiome associated with these medications may also indirectly impact the vaginal microbiome due to the gut-vagina axis." Beyond this, some reports have suggested that Ozempic and other GLP-1-based drugs may impact fertility, with numerous anecdotal cases of women getting pregnant on Ozempic despite using birth control
Cardiovascular context